For citations:
Vikulova O.K., Atanesyan R.A., Movsesyan S.D., Kasatkina Yu.P., Perevyazka A.A., Zaytseva E.L., Kharakhulakh M.I., Andreeva N.V., Krivosheyeva I.A., Vorobyev S.V., Saprina T.V., Avaliani D.A., Prudnikova M.A., Shestakova M.V., Mokrysheva N.G. Real-world effectiveness and safety of fixed-ratio combination insulin glargine 100 u/ml plus lixisenatide in adults with type 2 diabetes (T2DM): subanalysis of the international, multicentre, prospective observational study SUCCESS in the Russian population. Diabetes mellitus. 2024;27(5):468-479. (In Russ.) https://doi.org/10.14341/DM13236
 
        
        This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
 
                     
  
  
  
  
  
  Email this article
            Email this article 







































